|
US4180646A
(en)
|
1975-01-28 |
1979-12-25 |
Alza Corporation |
Novel orthoester polymers and orthocarbonate polymers
|
|
US4093709A
(en)
|
1975-01-28 |
1978-06-06 |
Alza Corporation |
Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
|
|
US4131648A
(en)
|
1975-01-28 |
1978-12-26 |
Alza Corporation |
Structured orthoester and orthocarbonate drug delivery devices
|
|
US4391797A
(en)
|
1977-01-05 |
1983-07-05 |
The Children's Hospital Medical Center |
Systems for the controlled release of macromolecules
|
|
US4718433A
(en)
|
1983-01-27 |
1988-01-12 |
Feinstein Steven B |
Contrast agents for ultrasonic imaging
|
|
DE3313946A1
(de)
|
1983-04-15 |
1984-10-18 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
|
|
DE3313947A1
(de)
|
1983-04-15 |
1984-10-18 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
|
|
DE3834705A1
(de)
|
1988-10-07 |
1990-04-12 |
Schering Ag |
Ultraschallkontrastmittel aus gasblaeschen und fettsaeure enthaltenden mikropartikeln
|
|
US4900540A
(en)
|
1983-06-20 |
1990-02-13 |
Trustees Of The University Of Massachusetts |
Lipisomes containing gas for ultrasound detection
|
|
US4899755A
(en)
|
1985-05-08 |
1990-02-13 |
The General Hospital Corporation |
Hepatobiliary NMR contrast agents
|
|
MX174467B
(es)
|
1986-01-23 |
1994-05-17 |
Squibb & Sons Inc |
1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
|
|
US5021556A
(en)
|
1987-07-22 |
1991-06-04 |
Neorx Corporation |
Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides
|
|
IE61591B1
(en)
|
1987-12-29 |
1994-11-16 |
Molecular Biosystems Inc |
Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production
|
|
US4844882A
(en)
|
1987-12-29 |
1989-07-04 |
Molecular Biosystems, Inc. |
Concentrated stabilized microbubble-type ultrasonic imaging agent
|
|
US5075099A
(en)
|
1988-05-31 |
1991-12-24 |
Neorx Corporation |
Metal radionuclide chelating compounds for improved chelation kinetics
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5364613A
(en)
|
1989-04-07 |
1994-11-15 |
Sieving Paul F |
Polychelants containing macrocyclic chelant moieties
|
|
WO1991003200A1
(en)
|
1989-08-28 |
1991-03-21 |
The General Hospital Corporation |
Hydroxy-aryl metal chelates for diagnostic nmr imaging
|
|
US5118797A
(en)
|
1989-08-28 |
1992-06-02 |
E. R. Squibb & Sons, Inc. |
Rhenium tris dioxime complexes
|
|
US5585112A
(en)
*
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
|
US5305757A
(en)
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
|
US5469854A
(en)
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
|
US6146657A
(en)
*
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
|
US5123414A
(en)
|
1989-12-22 |
1992-06-23 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
|
US5230882A
(en)
|
1989-12-22 |
1993-07-27 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
|
US5871959A
(en)
*
|
1989-12-27 |
1999-02-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of producing hepatocycte growth factor/scatter factor and related cell lines
|
|
CA2034042C
(en)
|
1990-01-18 |
1999-08-17 |
Adrian D. Nunn |
Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group
|
|
US5556610A
(en)
|
1992-01-24 |
1996-09-17 |
Bracco Research S.A. |
Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method
|
|
IN172208B
(https=)
|
1990-04-02 |
1993-05-01 |
Sint Sa |
|
|
US5578292A
(en)
|
1991-11-20 |
1996-11-26 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
US5445813A
(en)
|
1992-11-02 |
1995-08-29 |
Bracco International B.V. |
Stable microbubble suspensions as enhancement agents for ultrasound echography
|
|
US5183653A
(en)
|
1990-04-13 |
1993-02-02 |
E. R. Squibb & Sons, Inc. |
Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds
|
|
US5137928A
(en)
|
1990-04-26 |
1992-08-11 |
Hoechst Aktiengesellschaft |
Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
|
|
AU636481B2
(en)
|
1990-05-18 |
1993-04-29 |
Bracco International B.V. |
Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
|
|
US5173298A
(en)
|
1990-09-27 |
1992-12-22 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery vehicle suspensions
|
|
US5367080A
(en)
|
1990-11-08 |
1994-11-22 |
Sterling Winthrop Inc. |
Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
|
|
DE69230525T2
(de)
|
1991-02-08 |
2000-06-21 |
Diatide, Inc. |
Technetium-99m markierte Polypeptide zur Bildformung
|
|
US5849261A
(en)
|
1991-02-08 |
1998-12-15 |
Diatide, Inc. |
Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
|
|
US5965107A
(en)
|
1992-03-13 |
1999-10-12 |
Diatide, Inc. |
Technetium-99m labeled peptides for imaging
|
|
DE69232718T2
(de)
|
1991-02-22 |
2003-04-03 |
American Cyanamid Co., Madison |
Identifizierung eines menschlichen rezeptor-tyrosinkinasegens
|
|
GB9106686D0
(en)
|
1991-03-28 |
1991-05-15 |
Hafslund Nycomed As |
Improvements in or relating to contrast agents
|
|
GB9106673D0
(en)
|
1991-03-28 |
1991-05-15 |
Hafslund Nycomed As |
Improvements in or relating to contrast agents
|
|
DK0586524T3
(https=)
|
1991-06-03 |
1997-05-20 |
Nycomed Imaging As |
|
|
FI940027A7
(fi)
|
1991-07-05 |
1994-01-04 |
Nycomed Imaging As |
Parannuksia itse varjoaineisiin tai parannuksia, jotka liittyvät niihi n
|
|
US5808091A
(en)
|
1991-10-29 |
1998-09-15 |
Bracco International B.V. |
Rhenium and technetium complexes containing a hypoxia localizing moiety
|
|
GB9200387D0
(en)
|
1992-01-09 |
1992-02-26 |
Nycomed As |
Improvements in or relating to contrast agents
|
|
GB9200391D0
(en)
|
1992-01-09 |
1992-02-26 |
Nycomed As |
Improvements in or relating to contrast agents
|
|
GB9200388D0
(en)
|
1992-01-09 |
1992-02-26 |
Nycomed As |
Improvements in or relating to contrast agents
|
|
IL104084A
(en)
|
1992-01-24 |
1996-09-12 |
Bracco Int Bv |
Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
|
|
US5861301A
(en)
|
1992-02-20 |
1999-01-19 |
American Cayanamid Company |
Recombinant kinase insert domain containing receptor and gene encoding same
|
|
US5877289A
(en)
|
1992-03-05 |
1999-03-02 |
The Scripps Research Institute |
Tissue factor compositions and ligands for the specific coagulation of vasculature
|
|
US5965132A
(en)
*
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US5316921A
(en)
*
|
1992-05-18 |
1994-05-31 |
Genentech, Inc. |
Single-chain hepatocyte growth factor variants
|
|
ATE222603T1
(de)
*
|
1992-05-18 |
2002-09-15 |
Genentech Inc |
Hepatozytwachstumfaktor variante
|
|
EP0656069A4
(en)
*
|
1992-08-10 |
1996-07-10 |
Cambridge Neuroscience Inc |
CELL PROLIFERATION INHIBITORS, THEIR PRODUCTION AND USE.
|
|
AU687727B2
(en)
|
1992-10-28 |
1998-03-05 |
Genentech Inc. |
Vascular endothelial cell growth factor antagonists
|
|
US5608110A
(en)
|
1993-06-15 |
1997-03-04 |
Bracco International B.V. |
Heteroatom-bearing ligands and metal complexes thereof
|
|
PL312387A1
(en)
|
1993-07-02 |
1996-04-15 |
Molecular Biosystems Inc |
Proteinous microbeads of encapsulated non-dissolving gas and method of making them and their application as ultrasonic visualisation medium
|
|
ES2114209T3
(es)
|
1993-07-19 |
1998-05-16 |
Resolution Pharm Inc |
Queladores de radionuclidos de tipo hidrazino que tienen una configuracion n3s.
|
|
US5798091A
(en)
|
1993-07-30 |
1998-08-25 |
Alliance Pharmaceutical Corp. |
Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
|
|
US5574140A
(en)
|
1993-09-03 |
1996-11-12 |
Resolution Pharmaceutical Inc. |
Hydrazino-type N2 S2 chelators
|
|
PT682530E
(pt)
|
1993-12-15 |
2003-06-30 |
Bracco Research Sa |
Misturas de gases uteis como meios de contraste para ultrassons
|
|
GB9402867D0
(en)
|
1994-02-15 |
1994-04-06 |
Nycomed Imaging As |
Improvements in or relating to contrast agents
|
|
EP0751992B1
(en)
*
|
1994-03-08 |
2005-11-09 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
JP2891647B2
(ja)
|
1994-03-11 |
1999-05-17 |
株式会社日本触媒 |
有機スルフィド化合物及びその製造方法
|
|
US5770565A
(en)
|
1994-04-13 |
1998-06-23 |
La Jolla Cancer Research Center |
Peptides for reducing or inhibiting bone resorption
|
|
US5582814A
(en)
|
1994-04-15 |
1996-12-10 |
Metasyn, Inc. |
1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
|
|
CA2188292A1
(en)
|
1994-04-20 |
1995-11-02 |
Larry Margerum |
Contrast agents
|
|
US5707624A
(en)
*
|
1994-06-03 |
1998-01-13 |
The Regents Of The University Of Michigan |
Treatment of Kaposi's sarcoma by inhibition of scatter factor
|
|
US5650135A
(en)
|
1994-07-01 |
1997-07-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Non-invasive localization of a light-emitting conjugate in a mammal
|
|
US5662885A
(en)
|
1994-07-22 |
1997-09-02 |
Resolution Pharmaceuticals Inc. |
Peptide derived radionuclide chelators
|
|
GB9417941D0
(en)
|
1994-09-06 |
1994-10-26 |
Nycomed Imaging As |
Improvements in or relating to contrast agents
|
|
US5556939A
(en)
|
1994-10-13 |
1996-09-17 |
Merck Frosst Canada, Inc. |
TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
|
|
US6645933B1
(en)
*
|
1995-08-01 |
2003-11-11 |
Helsinki University Licensing Ltd. Oy |
Receptor ligand VEGF-C
|
|
US6221839B1
(en)
*
|
1994-11-14 |
2001-04-24 |
Helsinki University Licensing Ltd. Oy |
FIt4 ligand and methods of use
|
|
US6245530B1
(en)
*
|
1995-08-01 |
2001-06-12 |
Ludwig Institute For Cancer Research |
Receptor ligand
|
|
US6403088B1
(en)
*
|
1995-08-01 |
2002-06-11 |
Helsinki University Licensing, Ltd. |
Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3)
|
|
US6333021B1
(en)
|
1994-11-22 |
2001-12-25 |
Bracco Research S.A. |
Microcapsules, method of making and their use
|
|
DE4445065A1
(de)
|
1994-12-07 |
1996-06-13 |
Diagnostikforschung Inst |
Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung
|
|
IL116328A
(en)
|
1994-12-16 |
1999-09-22 |
Bracco Research Sa |
Frozen suspension of gas microbubbles in frozen aqueous carrier for use as contrast agent in ultrasonic imaging
|
|
TW319763B
(https=)
|
1995-02-01 |
1997-11-11 |
Epix Medical Inc |
|
|
GB9502065D0
(en)
|
1995-02-02 |
1995-03-22 |
Nycomed Imaging As |
Contrast media
|
|
US5686292A
(en)
*
|
1995-06-02 |
1997-11-11 |
Genentech, Inc. |
Hepatocyte growth factor receptor antagonist antibodies and uses thereof
|
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
|
EP0831932B1
(en)
|
1995-06-07 |
2004-05-06 |
Imarx Pharmaceutical Corp. |
Novel targeted compositions for diagnostic and therapeutic use
|
|
US6361946B1
(en)
*
|
1997-02-05 |
2002-03-26 |
Licentia Ltd |
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
|
|
ES2202469T5
(es)
*
|
1995-09-08 |
2011-06-06 |
Genentech, Inc. |
Proteína relacionada con el vegf.
|
|
AU1116297A
(en)
|
1995-11-08 |
1997-05-29 |
Immunex Corporation |
Flk-1 binding protein
|
|
US5837680A
(en)
|
1996-02-16 |
1998-11-17 |
Children's Medical Center Corporation |
Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
|
|
ES2197986T3
(es)
|
1996-02-19 |
2004-01-16 |
Amersham Health As |
Mejoras introducidas en o relacionadas con agentes de contraste.
|
|
AU726914B2
(en)
|
1996-04-01 |
2000-11-23 |
Epix Pharmaceuticals, Inc. |
Bioactivated diagnostic imaging contrast agents
|
|
NZ334365A
(en)
|
1996-08-02 |
1999-10-28 |
Nycomed Imaging As |
Use of a contrast agent comprising microbubbles of biocompatible gas stabilised by opsonisable amphiphilic material for ultrasound imaging of the liver
|
|
TW320761B
(en)
*
|
1996-10-03 |
1997-11-21 |
Mos Electronics Taiwan Inc |
Manufacturing method of high density DRAM with cylindrical stack capacitor
|
|
JP2001502349A
(ja)
|
1996-10-21 |
2001-02-20 |
ニユコメド・イメージング・アクシエセルカペト |
造影剤におけるまたはこれに関する改良
|
|
EP0991427A2
(en)
|
1996-10-28 |
2000-04-12 |
Marsden, John Christopher |
Improvements in or relating to diagnostic/therapeutic agents
|
|
ATE314097T1
(de)
|
1996-10-28 |
2006-01-15 |
Amersham Health As |
Kontrastmittel
|
|
US6331289B1
(en)
*
|
1996-10-28 |
2001-12-18 |
Nycomed Imaging As |
Targeted diagnostic/therapeutic agents having more than one different vectors
|
|
US6261537B1
(en)
*
|
1996-10-28 |
2001-07-17 |
Nycomed Imaging As |
Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
|
|
AU733495B2
(en)
*
|
1996-10-28 |
2001-05-17 |
Nycomed Imaging As |
Improvements in or relating to diagnostic/therapeutic agents
|
|
GB9708265D0
(en)
|
1997-04-24 |
1997-06-18 |
Nycomed Imaging As |
Contrast agents
|
|
ES2206689T3
(es)
|
1996-10-28 |
2004-05-16 |
Amersham Health As |
Agentes de contraste.
|
|
WO1998018498A2
(en)
|
1996-10-28 |
1998-05-07 |
Marsden, John, Christopher |
Improvements in or relating to diagnostic/therapeutic agents
|
|
WO1998018501A2
(en)
|
1996-10-28 |
1998-05-07 |
Marsden, John, Christopher |
Improvements in or relating to diagnostic/therapeutic agents
|
|
US7125714B2
(en)
*
|
1997-02-05 |
2006-10-24 |
Licentia Ltd. |
Progenitor cell materials and methods
|
|
US5919967A
(en)
|
1997-04-11 |
1999-07-06 |
Epix Medical, Inc. |
Process for synthesizing phosphodiesters
|
|
DE19717904A1
(de)
|
1997-04-23 |
1998-10-29 |
Diagnostikforschung Inst |
Säurelabile und enzymatisch spaltbare Farbstoffkonstrukte zur Diagnostik mit Nahinfrarotlicht und zur Therapie
|
|
US5886142A
(en)
|
1997-05-20 |
1999-03-23 |
Thomas Jefferson University |
Radiolabeled thrombus imaging agents
|
|
US6245318B1
(en)
|
1997-05-27 |
2001-06-12 |
Mallinckrodt Inc. |
Selectively binding ultrasound contrast agents
|
|
IL120943A
(en)
|
1997-05-29 |
2004-03-28 |
Univ Ben Gurion |
A system for administering drugs through the skin
|
|
GB9712525D0
(en)
|
1997-06-16 |
1997-08-20 |
Nycomed Imaging As |
Method
|
|
WO1998058053A1
(en)
*
|
1997-06-18 |
1998-12-23 |
Merck & Co., Inc. |
Human receptor tyrosine kinase, kdr
|
|
AU742438C
(en)
|
1997-10-02 |
2003-05-22 |
Lantheus Medical Imaging, Inc. |
Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
|
|
CA2313390A1
(en)
|
1997-12-09 |
1999-06-17 |
Children's Medical Center Corporation |
Peptide antagonists of vascular endothelial growth factor
|
|
US6165458A
(en)
|
1997-12-26 |
2000-12-26 |
Pharmaderm Laboratories Ltd. |
Composition and method for dermal and transdermal administration of a cytokine
|
|
JP4772958B2
(ja)
|
1998-02-09 |
2011-09-14 |
ブラッコ・リサーチ・ソシエテ・アノニム |
生物学的に活性な媒質の標的に向けた送達
|
|
CA2320339A1
(en)
|
1998-02-11 |
1999-08-19 |
Resolution Pharmaceuticals Inc. |
Angiogenesis targeting molecules
|
|
US20020136721A1
(en)
*
|
1998-02-17 |
2002-09-26 |
Schwall Ralph H. |
Hepatocyte growth factor receptor antagonists and uses thereof
|
|
EP1068224B1
(en)
|
1998-03-31 |
2005-05-11 |
Bristol-Myers Squibb Pharma Company |
Pharmaceuticals for the imaging of angiogenic disorders
|
|
US6093382A
(en)
|
1998-05-16 |
2000-07-25 |
Bracco Research Usa Inc. |
Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
|
|
JP2002529421A
(ja)
|
1998-11-06 |
2002-09-10 |
ビーエーエスエフ アクチェンゲゼルシャフト |
血管過浸透性の阻害方法
|
|
US6312665B1
(en)
|
1998-12-21 |
2001-11-06 |
Generex Pharmaceuticals Incorporated |
Aerosol formulations for buccal and pulmonary application
|
|
JP2002542766A
(ja)
*
|
1999-03-12 |
2002-12-17 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
５０個のヒト分泌タンパク質
|
|
AU3249300A
(en)
*
|
1999-03-12 |
2000-10-04 |
Human Genome Sciences, Inc. |
47 human secreted proteins
|
|
US20090087878A9
(en)
*
|
1999-05-06 |
2009-04-02 |
La Rosa Thomas J |
Nucleic acid molecules associated with plants
|
|
US6294525B1
(en)
|
1999-09-01 |
2001-09-25 |
Molecumetics Ltd. |
Reverse-turn mimetics and methods relating thereto
|
|
GB9928950D0
(en)
|
1999-12-07 |
2000-02-02 |
Metris Therapeutics Limited |
Binding protein
|
|
WO2001052875A1
(en)
*
|
2000-01-18 |
2001-07-26 |
Ludwig Institute For Cancer Research |
Vegf-d/vegf-c/vegf peptidomimetic inhibitor
|
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
|
AU2001228742A1
(en)
*
|
2000-02-04 |
2001-08-14 |
Supratek Pharma, Inc. |
Ligand for vascular endothelial growth factor receptor
|
|
AU2001239884B2
(en)
|
2000-02-25 |
2006-08-10 |
Vegenics Limited |
Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins and screening methods for modulators
|
|
ATE284701T1
(de)
|
2000-03-02 |
2005-01-15 |
Ludwig Inst Cancer Res |
Methode zur behandlung von tumoren welche den vaskulären endothelialen wachstumsfaktor d exprimieren
|
|
US20020102260A1
(en)
*
|
2000-03-02 |
2002-08-01 |
Marc Achen |
Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue
|
|
US6769080B2
(en)
*
|
2000-03-09 |
2004-07-27 |
Texas Instruments Incorporated |
Scan circuit low power adapter with counter
|
|
US20010031485A1
(en)
|
2000-03-22 |
2001-10-18 |
Sibtech, Inc. |
Recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor fragments
|
|
EP1265635A1
(en)
|
2000-03-22 |
2002-12-18 |
Glaxo Group Limited |
Pharmaceutical comprising an agent that blocks the cell cycle and an antibody
|
|
AU4445601A
(en)
*
|
2000-03-31 |
2001-10-08 |
Centre National De La Recherche Scientifique-Cnrs |
Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
|
|
US20050100991A1
(en)
*
|
2001-04-12 |
2005-05-12 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
WO2001083693A2
(en)
|
2000-04-28 |
2001-11-08 |
Glaxo Group Limited |
Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses
|
|
AU2001264565B2
(en)
|
2000-05-03 |
2006-12-07 |
Vegenics Limited |
A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof
|
|
KR100457350B1
(ko)
*
|
2000-06-01 |
2004-11-16 |
이경림 |
ＩｇＥ-의존적 히스타민 방출인자(ＨＲＦ)의 수용체,ＨＲＦ 결합 펩타이드 및 그들을 코딩하는 핵산, 및그들의 용도
|
|
EP1166798A1
(en)
|
2000-06-23 |
2002-01-02 |
Schering Aktiengesellschaft |
Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/ Tie receptor function and their use
|
|
EP1166799A1
(en)
|
2000-06-28 |
2002-01-02 |
Schering Aktiengesellschaft |
Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/Tie receptor function and their use (II)
|
|
AU784231B2
(en)
|
2000-06-23 |
2006-02-23 |
Schering Aktiengesellschaft |
Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use (II)
|
|
EP1311277A4
(en)
|
2000-07-18 |
2004-08-25 |
Joslin Diabetes Center Inc |
METHODS OF FIBROSIS MODULATION
|
|
US20020091082A1
(en)
*
|
2000-09-13 |
2002-07-11 |
Aiello Lloyd P. |
Methods of modulating symptoms of hypertension
|
|
FR2814744B1
(fr)
*
|
2000-10-04 |
2002-11-29 |
Commissariat Energie Atomique |
Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese
|
|
US20030082103A1
(en)
*
|
2000-10-11 |
2003-05-01 |
Targesome, Inc. |
Targeted therapeutic lipid constructs having cell surface targets
|
|
US7611711B2
(en)
|
2001-01-17 |
2009-11-03 |
Vegenics Limited |
VEGFR-3 inhibitor materials and methods
|
|
CA2435503C
(en)
|
2001-01-19 |
2011-02-22 |
Ludwig Institute For Cancer Research |
Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
|
|
AU2002252631A1
(en)
|
2001-04-13 |
2002-10-28 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
JP2005518185A
(ja)
*
|
2001-06-04 |
2005-06-23 |
キュラジェン コーポレイション |
新規タンパク質およびそれをコード化する核酸
|
|
US20050069877A1
(en)
*
|
2001-06-22 |
2005-03-31 |
Gandhi Ameena R. |
Protein modification and maintenance molecules
|
|
AU2002362461A1
(en)
|
2001-10-01 |
2003-04-14 |
Targesome, Inc. |
Targeted therapeutic lipid constructs having cell surface targets
|
|
US6766860B2
(en)
*
|
2002-02-22 |
2004-07-27 |
Globalsantafe Corporation |
Multi-activity offshore drilling facility having a support for tubular string
|
|
US7211240B2
(en)
*
|
2002-03-01 |
2007-05-01 |
Bracco International B.V. |
Multivalent constructs for therapeutic and diagnostic applications
|
|
US7794693B2
(en)
*
|
2002-03-01 |
2010-09-14 |
Bracco International B.V. |
Targeting vector-phospholipid conjugates
|
|
EP1501357A4
(en)
|
2002-05-06 |
2009-10-21 |
Genentech Inc |
USE OF VEGF FOR THE TREATMENT OF BONE DEFECTS
|
|
ES2396368T3
(es)
*
|
2003-03-03 |
2013-02-21 |
Dyax Corporation |
Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos
|
|
CA2631716C
(en)
*
|
2005-12-09 |
2013-11-26 |
Bracco International B.V. |
Targeting vector-phospholipid conjugates
|
|
AU2009219437B2
(en)
*
|
2008-02-25 |
2014-10-16 |
Nestec S.A. |
Drug selection for breast cancer therapy using antibody-based arrays
|
|
US9801473B2
(en)
|
2012-09-13 |
2017-10-31 |
Kids Ii, Inc. |
Play yard with removable liner
|
|
EP3020171B1
(en)
|
2013-07-12 |
2017-12-20 |
Telefonaktiebolaget LM Ericsson (publ) |
Method for enabling control of data packet flows belonging to different access technologies
|